Govt Panel Directs Serum Institute of India to Add Guillain-Barre Syndrome Warning as Rare Side Effect of Covishield Vaccine Susmita Roy26 Feb 2025 8:44 PM ISTNew Delhi: A panel functional under the Health Ministry has recommended that the Serum Institute of India (SII) update the product information for its...
Vitamin D supplementation could lead to better IBS management with low risk of adverse events: Study Dr. Shravani Dali27 Jan 2025 8:45 AM ISTVitamin D supplementation could lead to better IBS management with a low risk of adverse events suggests a new study published in the Advances in...
Association of activated clotting time with hemorrhagic or thromboembolic events controversial and limited, suggests research Dr Monish Raut9 Jan 2025 8:15 AM ISTExtracorporeal membrane oxygenation (ECMO) necessitates widespread anticoagulation to decrease the chances of thromboembolic events and circuit...
Late-onset RA Patients Face Greater Decline in Physical Function and higher incidence of adverse events, finds research Dr Riya Dave26 Dec 2024 8:45 PM ISTResearchers have discovered that, although patients with late-onset rheumatoid arthritis (LORA) and younger-onset rheumatoid arthritis (YORA) show...
Vericiguat safe drug for use in patients with coronary artery disease, finds research Dr Riya Dave24 Dec 2024 9:00 AM ISTResearchers have identified that vericiguat, a new drug for heart failure, is safe in patients with coronary artery disease. A recent study showed...
Deucravacitinib Found to Be Safe and Effective for Psoriasis Over 3 Years: JAMA Dr Riya Dave5 Dec 2024 8:15 PM ISTResearchers have found that deucravacitinib for long-term treatment is well tolerated and has a sustained clinical response in the management of...
Eli Lilly's Experimental Drug Muvalaplin Lowers Inherited Cholesterol by Up to 86 percent Farhat Nasim20 Nov 2024 1:05 PM ISTRuth Gimeno, Lilly's group vice president for diabetes and metabolic research, said Eli Lilly is weighing next steps for advancing to late stage...
Medical Bulletin 15/ November/ 2024 Dr. Bhumika Maikhuri15 Nov 2024 3:00 PM ISTHere are the top medical news for the day:Clinical Trial Finds Well Tolerated Vaccine for Aggressive Breast CancerA small clinical trial shows...
Adverse Events Affect Over 38% Surgery Patients: BMJ Study Finds Dr. Bhumika Maikhuri15 Nov 2024 8:30 AM ISTAdverse events affect more than a third (38%) of adults undergoing surgery, finds a study of admissions to 11 hospitals in the US state of...
Phentolamine Ophthalmic Solution Reverses Mydriasis Faster, suggests study Dr Riya Dave2 Oct 2024 8:15 PM ISTAccording to research, the ophthalmic solution of phentolamine 0.75% (RYZUMV), developed by Ocuphire Pharma, strongly and quickly reverses...
Odanacatib safe and efficacious alternative for treatment of osteoporosis among postmenopausal women: Study Dr Riya Dave21 Sept 2024 2:00 AM ISTResearchers have found that odanacatib (ODN), a cathepsin K (CatK) inhibitor, is an effective and safe treatment option for postmenopausal...
Real-World Analysis of Tirzepatide Reveals Comparable Safety Profile to GLP-1 Receptor Agonists Medha Baranwal20 Sept 2024 9:30 AM ISTItaly: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety profile of tirzepatide...
